Disparities in health care, which are complex and pervasive, have implications for the assessment and treatment of opioid use disorder. Awareness of some of the core disparities provides clinicians with an opportunity to educate others, advocate assertively on behalf of patients, and anticipate treatment challenges.
Contributors to health care disparities at the provider and systems levels include the following:
- Explicit and implicit clinician biases, such as misperceptions that African Americans experience less pain and may have greater addiction propensity.
- A lower probability of receiving buprenorphine treatment among people of color relative to higher income and non-Hispanic White counterparts.
- Misperceptions that patients with low health literacy, limited English language fluency, or who do not understand medication instructions will be less compliant, leading to attributions of patient noncompliance.
- Lack of culturally specific services.
Patient-level contributors to health care disparities include:
- Hesitation to seek or accept professional intervention due to concerns regarding misdiagnosis, cultural mistrust, and cultural norms that may be inconsistent with treatment (e.g., self-reliance, beliefs that pain is inevitable and can be managed without prescription medication, fear of substance use disorders, and use of complementary or alternative treatments).
- Greater reticence to report opioid use due to fears of criminal prosecution or removal of parental rights (people of color are more likely to experience punitive criminal justice outcomes).
Given these and other biases, the following recommendations are provided for consideration as part of an integrated approach to the complex interactions between race, ethnicity, socioeconomic status, cultural context, and geography.


